January 25, 2021
Pre-forum virtual workshops have a registration fee of $199
11:30 am - 1:00 pm
EST
Investigational New Drug (IND) Submission Readiness
Anne Chew -
Executive Deputy Director, Center for Cellular Immunotherapies,
University of Pennsylvania- Penn Medicine
Shana Hardy - Biologist, Office of Tissues and Advanced Therapies Division of Clinical Evaluation and Pharm/Tox, FDA/CBER
Tal Salz PhD - Cell and Gene Therapy Reviewer, Office of Tissues and Advanced Therapies Division of Cellular and Gene Therapies, Food and Drug Administration (FDA)/CBER
Take part in a workshop to ensure preparedness for the process for IND applications submission with leaders from academia as well as FDA reviewers.
Anne Chew
Executive Deputy Director, Center for Cellular ImmunotherapiesUniversity of Pennsylvania- Penn Medicine
Shana Hardy
Biologist, Office of Tissues and Advanced Therapies Division of Clinical Evaluation and Pharm/ToxFDA/CBER
Tal Salz PhD
Cell and Gene Therapy Reviewer, Office of Tissues and Advanced Therapies Division of Cellular and Gene TherapiesFood and Drug Administration (FDA)/CBER
